Citigroup’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
61,750
-102,724
| -62% | -$2.16M | ﹤0.01% | 2357 |
|
|
2025
Q1 | $2.69M | Buy |
164,474
+38,310
| +30% | +$628K | ﹤0.01% | 1852 |
|
|
2024
Q4 | $3.24M | Buy |
126,164
+55,482
| +78% | +$1.43M | ﹤0.01% | 1783 |
|
|
2024
Q3 | $2.24M | Buy |
70,682
+24,605
| +53% | +$779K | ﹤0.01% | 1962 |
|
|
2024
Q2 | $1.62M | Sell |
46,077
-159,039
| -78% | -$5.58M | ﹤0.01% | 1911 |
|
|
2024
Q1 | $9M | Buy |
205,116
+115,418
| +129% | +$5.06M | 0.01% | 942 |
|
|
2023
Q4 | $3.19M | Buy |
89,698
+34,444
| +62% | +$1.23M | ﹤0.01% | 1362 |
|
|
2023
Q3 | $1.49M | Buy |
55,254
+1,967
| +4% | +$53.1K | ﹤0.01% | 1648 |
|
|
2023
Q2 | $1.25M | Sell |
53,287
-50,873
| -49% | -$1.2M | ﹤0.01% | 2073 |
|
|
2023
Q1 | $1.43M | Buy |
104,160
+34,023
| +49% | +$467K | ﹤0.01% | 1752 |
|
|
2022
Q4 | $1.27M | Sell |
70,137
-35,373
| -34% | -$643K | ﹤0.01% | 1838 |
|
|
2022
Q3 | $1.57M | Sell |
105,510
-97,988
| -48% | -$1.46M | ﹤0.01% | 1771 |
|
|
2022
Q2 | $2.81M | Buy |
203,498
+181,519
| +826% | +$2.5M | ﹤0.01% | 1380 |
|
|
2022
Q1 | $246K | Sell |
21,979
-70,273
| -76% | -$787K | ﹤0.01% | 3282 |
|
|
2021
Q4 | $2.18M | Buy |
92,252
+67,028
| +266% | +$1.58M | ﹤0.01% | 1912 |
|
|
2021
Q3 | $643K | Buy |
25,224
+21,894
| +657% | +$558K | ﹤0.01% | 2725 |
|
|
2021
Q2 | $70K | Buy |
3,330
+1,604
| +93% | +$33.7K | ﹤0.01% | 3994 |
|
|
2021
Q1 | $41K | Sell |
1,726
-2,157
| -56% | -$51.2K | ﹤0.01% | 4150 |
|
|
2020
Q4 | $54K | Buy |
3,883
+3,118
| +408% | +$43.4K | ﹤0.01% | 4045 |
|
|
2020
Q3 | $10K | Sell |
765
-861
| -53% | -$11.3K | ﹤0.01% | 4308 |
|
|
2020
Q2 | $23K | Buy |
1,626
+582
| +56% | +$8.23K | ﹤0.01% | 4160 |
|
|
2020
Q1 | $4K | Buy |
1,044
+874
| +514% | +$3.35K | ﹤0.01% | 4845 |
|
|
2019
Q4 | $1K | Buy |
+170
| New | +$1K | ﹤0.01% | 5037 |
|